Beneficial effect of anti-interleukin-33 on the murine model of allergic inflammation of the lower airway

Journal of Asthma

Volumn 49, Issue 7, 2012, Pages 738-743

  Kim, Young Hyo ^a   Park, Chang Shin ^a   Lim, Dae Hyun ^a   Ahn, Sung Hye ^a   Son, Byong Kwan ^a   Kim, Jeong Hee ^a   Jang, Tae Young ^a  

^a Inha University School of Medicine   (South Korea)

Author keywords

Airway; Allergy; Anti IL 33; Bronchoalveolar lavage; Murine; Ovalbumin

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 33; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY INTERLEUKIN 33; OVALBUMIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; LUNG LAVAGE; LYMPHOCYTE; MOUSE; NEUTROPHIL; NONHUMAN;

ANIMALS; ANTIBODIES; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; INTERLEUKINS; MICE; MICE, INBRED BALB C; OVALBUMIN;

EID: 84865321188     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2012.702841     Document Type: Article

References (22)

1. Baekkevold ES, Roussigne M, Yamanaka T, Johansen FE, Jahnsen FL, Amalric F, Brandtzaeg P, Erard M, Haraldsen G, Girard JP. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 2003; 163 (1):69-79. (Pubitemid 36759592)
2. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor- related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23 (5):479-490. (Pubitemid 41587888)
3. Kurowska-Stolarska M, Hueber A, Stolarski B, McInnes IB. Interleukin- 33: a novel mediator with a role in distinct disease pathologies. J Intern Med 2011; 269 (1):29-35.
4. Lloyd CM. IL-33 family members and asthma - bridging innate and adaptive immune responses. Curr Opin Immunol 2010; 22 (6):800-806.
5. Coyle AJ, Lloyd C, Tian J, Nguyen T, Erikkson C, Wang L, Ottoson P, Persson P, Delaney T, Lehar S, Lin S, Poisson L, Meisel C, Kamradt T, Bjerke T, Levinson D, Gutierrez-Ramos JC. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999; 190 (7):895-902. (Pubitemid 29480818)
6. Xu D, Chan WL, Leung BP, Huang F, Wheeler R, Piedrafita D, Robinson JH, Liew FY. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998; 187 (5):787-794. (Pubitemid 28115194)
7. Lüthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C, Brumatti G, Taylor RC, Kersse K, Vandenabeele P, Lavelle EC, Martin SJ. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009; 31 (1):84-98.
8. Talabot-Ayer D, Lamacchia C, Gabay C, Palmer G. Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem 2009; 284 (29):19420-19426.
9. Tago K, Noda T, Hayakawa M, Iwahana H, Yanagisawa K, Yashiro T, Tominaga S. Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V. Biochem Biophys Res Commun 2001; 285 (5):1377-1383. (Pubitemid 32912936)
10. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 2008; 3 (10):e3331.
11. Kurowska-Stolarska M, Kewin P, Murphy G, Russo RC, Stolarski B, Garcia CC, Komai-Koma M, Pitman N, Li Y, Niedbala W, McKenzie AN, Teixeira MM, Liew FY, Xu D. IL-33 induces antigen-specific IL- 5 T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 2008; 181 (7):4780-4790.
12. Kearley J, Buckland KF, Mathie SA, Lloyd CM. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 2009; 179 (9):772-781.
13. Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 2009; 386 (1):181-185.
14. Oshikawa K, Yanagisawa K, Tominaga S, Sugiyama Y. Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy 2002; 32 (10):1520-1526. (Pubitemid 35278923)
15. Pushparaj PN, Tay HK, H'ng SC, Pitman N, Xu D, McKenzie A, Liew FY, Melendez AJ. The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci USA 2009; 106 (24):9773-9778.
16. Kondo Y, Yoshimoto T, Yasuda K, Futatsugi-Yumikura S, Morimoto M, Hayashi N, Hoshino T, Fujimoto J, Nakanishi K. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 2008; 20 (6):791-800. (Pubitemid 351791523)
17. Saito H, Matsumoto K, Denburg AE, Crawford L, Ellis R, Inman MD, Sehmi R, Takatsu K, Matthaei KI, Denburg JA. Pathogenesis of murine experimental allergic rhinitis: a study of local and systemic consequences of IL-5 deficiency. J Immunol 2002; 168 (6):3017-3023. (Pubitemid 34211683)
18. Kumar RK, Herbert C, Webb DC, Li L, Foster PS. Effects of anticytokine therapy in a mouse model of chronic asthma. Am J Respir Crit Care Med 2004; 170 (10):1043-1048. (Pubitemid 39488615)
19. Foster PS, Ming Y, Matthei KI, Young IG, Temelkovski J, Kumar RK. Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma. Lab Invest 2000; 80 (5): 655-662. (Pubitemid 30340649)
20. Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008; 121 (6):1484-1490. (Pubitemid 351787349)
21. Suzukawa M, Koketsu R, Iikura M, Nakae S, Matsumoto K, Nagase H, Saito H, Matsushima K, Ohta K, Yamamoto K, Yamaguchi M. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest 2008; 88 (11):1245-1253.
22. Kim YH, Yang TY, Park CS, Ahn SH, Son BK, Kim JH, Lim DH, Jang TY. Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Allergy 2012; 67 (2):183-90.